-
Celgene Corp
-
Sector
Health Care
-
Industry
Biotechnology
-
Company web
Link
-
Employees
Full Time Employees: 7,132
-
Executives
- Robert Hugin
- Scott Smith
- Mark Alles
- Peter Kellogg
- Terrie Curran
- Michael Pehl
- Rupert Vessey
- Gerald Masoudi
- Michael Casey
- Michael Bonney
-
Company address
- 86 Morris Avenue
- Summit, NJ 07901
- United States of America
- 1-908-673-9000
-
Investor Relation Site
Link
Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis, psoriasis, and ankylosing spondylitis; and ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers. The company’s products also include VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and acute myeloid leukemia (AML); THALOMID to treat patients with multiple myeloma and erythema nodosum leprosum; and RITALIN and FOCALIN XR products. Its clinical stage products comprise OTEZLA for use in treating various immune-inflammatory diseases; luspatercept for beta-thalassemia and MDS; CC-486 to treat MDS, AML, and solid tumors; AG-881 for glioma with IDH mutations; LSD1 inhibitor to treat non-hodgkin lymphoma and solid tumors; CC-122 and CC-220 to treat hematological and solid tumor cancers, and inflammation and immunology diseases; and durvalumab, an anti-PDL-1 antibody, for multiple hematological cancers. The company has a strategic collaboration with BeiGene, Ltd. and Nimbus Therapeutics. It also has collaborative agreements with Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; Sutro Biopharma, Inc.; bluebird bio, Inc.; FORMA Therapeutics Holdings, LLC; OncoMed Pharmaceuticals, Inc.; NantBioScience, Inc.; AstraZeneca PLC; Lycera Corp.; Juno Therapeutics, Inc.; Nurix Inc.; Jounce Therapeutics, Inc.; and Dragonfly Therapeutics, Inc. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.
Celgene Corp: Slide deck
- CELG - Q3 Earnings Presentation 25 Oct 2017: Slides deck
- CELG - Q2 Earnings Presentation 27 July 2017: Slides deck
- CELG - Q1 Earnings Presentation 27 April 2017: Slides deck
- CELG - Q4 Earnings Presentation 26 Jan 2017: Slides deck
- CELG - Q3 Earnings Presentation 27 Oct 2016: Slides deck
- CELG - Q2 Earnings Presentation 28 July 2016: Slides deck
- CELG - Q1 Earnings Presentation 28 April 2016: Slides deck